Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...
India has taken a significant step toward improving pediatric healthcare with the Union Health Ministry’s release of comprehensive national care guidelines for Diabetes Mellitus...